Chinese Insulin Wins FDA Nod: Sunshine Lake Pharma Breaks Into US Market
Sunshine Lake Pharma, the Chinese mainland’s first to gain FDA approval for a long‑acting insulin, is set to supply 18 million vials to the United States over 18 months.
Chinese pharma